1

Mini-antibodies Reactivate tumor suppressor p53: The New Pathway for Malignant Treatment

News Discuss 
A major advance in cancer investigation is emerging with the use of mini-antibodies to restore dysfunctional p53. This crucial tumor inhibitor protein is frequently lost in various kinds of cancer, resulting https://socialioapp.com/story6838495/vhh-fragments-reactivate-p53-the-promising-hope-for-malignant-management

Comments

    No HTML

    HTML is disabled


Who Upvoted this Story